- The 8 States Most Likely to Legalize Marijuana Next
- Dow 18,000: Why This Market Rally May Never Happen Again
- Express Scripts and AbbVie Drug-Pricing Deal Might Devastate Biotech Bull Market
- Gilead Sciences Is Not a Buy; It's Heading Lower on Price War: Jim Cramer
- BlackBerry Classic Review: A Bold Update for CrackBerry Fans
Merck is buying Cubist Pharmaceuticals, Amazon adds a 'make-an-offer' feature,' and General Mills launches ‘Cheerios + Ancient Grains.’
Mutual funds may be immensely popular among individual investors, but they are also highly inefficient, said Dr. Kenneth Kim, author of 'Mutual Funds Exposed.'
Liquid alternatives are a smart option to traditional equity index funds because investors in hedged funds are not forced to accept the market's volatility.
The sluggish Japanese and European economies will not slow down U.S. growth in the coming year, said Constance Hunter, Chief Economist at KPMG.
DBV Technologies profile in the U.S. has risen along with its stock since the French biotech listed its shares on the Nasdaq in October, said CEO Dr. Pierre-Henri Benhamou.
The best time of the year to buy municipal bonds is right now due to all the supply hitting the market, said Ron Schwartz.
Shares of Tumi have been range-bound in recent years, but a slew of new products will help the luggage-seller's stock breakout in 2015.
Wells Fargo will benefit from the talent exodus out of Merrill Lynch once the Bank of America retention contracts expire in the next year.
Buying socially responsible bonds does not require an investor to sacrifice returns for social benefit, said Stephen Liberatore.
Energy stocks are out of favor due to sinking oil prices, but rising yields are making them an attractive contrarian play, said Michael Ball.